Daniel Aletaha Selected Research

chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature

1/2022	The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.
1/2022	The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Aletaha Research Topics

Disease

110	Rheumatoid Arthritis 01/2024 - 04/2002
21	Arthritis (Polyarthritis) 03/2024 - 04/2007
19	Psoriatic Arthritis 03/2024 - 08/2009
17	Necrosis 12/2023 - 02/2005
16	Pain (Aches) 12/2023 - 03/2010
12	COVID-19 05/2023 - 11/2020
11	Rheumatic Diseases (Rheumatism) 01/2023 - 01/2010
10	Inflammation (Inflammations) 01/2023 - 06/2005
8	Ankylosing Spondylitis 01/2022 - 04/2007
7	Joint Diseases (Joint Disease) 01/2023 - 08/2007
5	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 01/2019
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 01/2019
4	Osteoarthritis 01/2022 - 10/2007
4	Gout 09/2014 - 07/2011
3	Axial Spondyloarthritis 12/2023 - 01/2023
3	Synovitis 12/2023 - 04/2014
3	Connective Tissue Diseases (Connective Tissue Disease) 11/2023 - 01/2022
3	Neoplasms (Cancer) 01/2023 - 06/2011
3	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 01/2016
3	Cryopyrin-Associated Periodic Syndromes 01/2022 - 01/2022
2	Vasculitis (Vasculitides) 12/2023 - 11/2023
2	Disease Progression 12/2023 - 01/2005
2	Respiratory Insufficiency (Respiratory Failure) 11/2023 - 07/2022
2	Spondylarthritis (Spinal Arthritis) 11/2023 - 01/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 01/2023
2	Human Influenza (Influenza) 05/2023 - 01/2018
2	Castleman Disease (Castleman's Disease) 01/2023 - 01/2022
2	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023 - 01/2022
2	Cytokine Release Syndrome 01/2023 - 01/2022
2	Giant Cell Arteritis (Horton Disease) 01/2023 - 01/2022
2	Adult-Onset Still's Disease 01/2023 - 01/2022
2	Neuromyelitis Optica (Devic's Disease) 01/2023 - 01/2022
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 01/2022
2	Bites and Stings (Sting) 01/2022 - 01/2022
2	Infections 01/2022 - 01/2021
2	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

30	Antirheumatic Agents (DMARD)IBA 03/2024 - 04/2002
22	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 01/2006
17	C-Reactive ProteinIBA 08/2023 - 03/2010
12	tocilizumab (atlizumab)FDA Link 01/2023 - 12/2007
12	GlucocorticoidsIBA 01/2023 - 02/2005
11	Infliximab (Remicade)FDA Link 01/2023 - 10/2007
10	Adalimumab (Humira)FDA Link 06/2023 - 05/2006
9	AutoantibodiesIBA 01/2023 - 05/2006
8	AntibodiesIBA 05/2023 - 03/2011
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 08/2009
7	CytokinesIBA 12/2023 - 06/2005
7	tofacitinibIBA 01/2023 - 01/2014
7	Rituximab (Mabthera)FDA Link 01/2023 - 12/2007
7	Etanercept (Enbrel)FDA Link 01/2023 - 10/2007
6	baricitinibIBA 01/2024 - 01/2014
6	GLPG0634IBA 12/2023 - 01/2020
6	ametantrone (HAQ)IBA 08/2015 - 09/2006
5	InterleukinsIBA 03/2024 - 01/2020
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 10/2007
5	sarilumabIBA 06/2023 - 06/2017
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2012
5	Janus Kinase InhibitorsIBA 01/2023 - 01/2017
5	Abatacept (Orencia)FDA Link 01/2023 - 12/2007
5	Biosimilar PharmaceuticalsIBA 01/2023 - 01/2014
5	Leflunomide (Arava)FDA LinkGeneric 01/2023 - 01/2014
5	golimumab FDA Link 01/2023 - 03/2014
5	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 10/2007
5	Rheumatoid FactorIBA 01/2022 - 03/2011
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020 - 01/2005
5	Prostaglandins AIBA 01/2020 - 09/2012
4	Messenger RNA (mRNA)IBA 11/2023 - 01/2022
4	upadacitinibIBA 06/2023 - 01/2020
4	VaccinesIBA 05/2023 - 10/2021
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2023 - 01/2014
4	Certolizumab Pegol FDA Link 01/2023 - 03/2014
4	Interleukin-1 (Interleukin 1)IBA 07/2022 - 09/2014
4	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 09/2010
4	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2014 - 10/2011
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2014 - 10/2011
3	mRNA VaccinesIBA 01/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2015
3	sirukumabIBA 01/2021 - 01/2017
3	amsonic acid (DAS)IBA 01/2020 - 11/2012
3	Neurotransmitter Agents (Neurotransmitter)IBA 09/2012 - 10/2011
3	Opioid Analgesics (Opioids)IBA 09/2012 - 10/2011
2	Interleukin-17 (Interleukin 17)IBA 03/2024 - 01/2020
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2023 - 01/2023
2	EnzymesIBA 11/2023 - 01/2021
2	ImmunosorbentsIBA 11/2023 - 01/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2023 - 01/2018
2	BNT162 VaccineIBA 05/2023 - 01/2023
2	Immunomodulating AgentsIBA 02/2023 - 01/2019
2	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2021
2	AntigensIBA 07/2022 - 01/2022
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2022
2	InterferonsIBA 01/2022 - 01/2022
2	cyclic citrullinated peptideIBA 01/2022 - 03/2011
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2022

Therapy/Procedure

53	Therapeutics 03/2024 - 12/2003
4	Pain Management 09/2012 - 10/2011
2	Precision Medicine 12/2023 - 01/2020
2	Knee Replacement Arthroplasty (Total Knee Replacement) 07/2023 - 01/2020